Relief Therapeutics Launches Level 1 ADR Program in the United States

GENEVA, SWITZERLAND / ACCESSWIRE / November 18, 2021 / RELIEF THERAPEUTICS Holding SA (SIX:RLF, OTCQB:RLFTF) (" Relief "), announced today that its Form F-6 registration statement has become effective, and that Relief has launched its Level 1 …